These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. Hoyer S. J Neural Transm (Vienna); 2002 Mar; 109(3):341-60. PubMed ID: 11956956 [Abstract] [Full Text] [Related]
24. Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications. Tumminia A, Vinciguerra F, Parisi M, Frittitta L. Int J Mol Sci; 2018 Oct 24; 19(11):. PubMed ID: 30355995 [Abstract] [Full Text] [Related]
34. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease. Freude S, Schilbach K, Schubert M. Curr Alzheimer Res; 2009 Jun 30; 6(3):213-23. PubMed ID: 19519303 [Abstract] [Full Text] [Related]
36. Mechanisms involved in cholesterol-induced neuronal insulin resistance. Taghibiglou C, Bradley CA, Gaertner T, Li Y, Wang Y, Wang YT. Neuropharmacology; 2009 Sep 30; 57(3):268-76. PubMed ID: 19523477 [Abstract] [Full Text] [Related]
37. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Olefsky JM, Kolterman OG. Am J Med; 1981 Jan 30; 70(1):151-68. PubMed ID: 7006388 [Abstract] [Full Text] [Related]